NCT04868942

Brief Summary

The aim of this study is to assess whether the protective measures can limit the contaminations by SARS-CoV-2 during the participation in a concert at a non-inferior level to a non-concert / current life situation. A randomized, monocentric, open-label, non-inferiority study comparing, in two phases, a group of volunteers participating in a concert, protected by established protection measures, to a group with no other constraints than national recommendations and obligations (2 concerts, one control group at each concert). Volunteer students, between 18 and 30 years old, at Aix-Marseille University, will be recruited.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2021

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 16, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

December 30, 2021

Status Verified

December 1, 2021

Enrollment Period

2 months

First QC Date

April 16, 2021

Last Update Submit

December 10, 2021

Conditions

Keywords

CoronavirusHealthy volunteersSocial distancingPreventionFace masks

Outcome Measures

Primary Outcomes (1)

  • SARS-CoV-2 conversion rates

    PCR on saliva sample

    6 to 7 days after attending to the musical event

Secondary Outcomes (5)

  • Respiratory virus conversion rates

    6 to 7 days after attending the concert

  • Types and importance of barriers to prevention measures

    1 to 2 day before attending the concert

  • Types and importance of levers for adherence to prevention measures

    1 to 2 days after attending the concert

  • Seroprevalence of SARS-CoV-2 in volunteers

    1 to 2 days before attending the concert

  • SARS-CoV-2 variants among participant positive cases

    6 to 7 days after attending the concert

Study Arms (2)

Participant assisting to the event

EXPERIMENTAL

Attending to musical event protected by established protection measures (protection kit, distancing, flow management, health mediation).

Other: Assisting to the event

Participant with no other constraints than national recommendations

NO INTERVENTION

A group control participant will not attend to the event

Interventions

Participant will attend a concert respecting the Following measures : * Individual protection kit: disposable FFP2 masks (3), Hydroalcoholic solution, disposable tissues, garbage bag, water bottle * Health mediation, information on barrier measures * Physical distancing (sitting participation) * Person flow management

Also known as: Attend a concert
Participant assisting to the event

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Student at Aix Marseille University
  • who has declared that he or she does not carry any risk factor for severe forms of the disease (HCSP criteria of 29/10/2020)
  • who has declared that he or she does not live under the same roof as a person who does carry such factors, and committed to strictly following the study's health protocol,
  • carrying a smartphone which is registered on the "TousAntiCovid" application (with Bluetooth activation), and agreeing to install the Maela application on the smartphone for remote medical monitoring.

You may not qualify if:

  • Volunteer with clinical signs of acute respiratory infectious disease
  • Volunteer living with a person with clinical signs of acute respiratory infectious disease
  • Volunteer with a risk factor for severe COVID-19
  • Volunteer who had a COVID-19 infection in the 3 months prior to the study
  • Volunteer who are not affiliated to the social security system
  • Volunteer vaccinated against COVID-19
  • Pregnant women and people living with pregnant women
  • Persons deprived of liberty
  • Adult with legal protection
  • Volunteer unable to comply with protective measures, at the concert or at home
  • Volunteer participating in another clinical research study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronavirus Infections

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Fabrice Simon, Prof

    Faculté des Sciences Médicales et Paramédicales

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomised, monocentric, open-label, non-inferiority study comparing, in two phases, a group of volunteers participating in a concert, protected by established protection measures (protection kit, distancing, flow management, health mediation), to a group with no other constraints than national recommendations and obligations (2 concerts, one control group at each concert).
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 16, 2021

First Posted

May 3, 2021

Study Start

May 1, 2021

Primary Completion

July 1, 2021

Study Completion

May 1, 2022

Last Updated

December 30, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share